This Week in Addiction Medicine from ASAM
By American Society of Addiction Medicine
Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Category: Medicine
Open in Apple Podcasts
Open RSS feed
Open Website
Rate for this podcast
Subscribers: 1
Reviews: 0
Episodes: 100
Description
An audio source and summary of the top stories from the field of addiction medicine.
| Episode | Date |
|---|---|
|
Lead: Preventing deaths after prison release
|
Apr 23, 2024 |
|
Lead: Telling the story of the opioid crisis
|
Apr 16, 2024 |
|
Lead: Impact of jail-based methadone or buprenorphine treatment on non-fatal opioid overdose after incarceration
|
Apr 09, 2024 |
|
Lead: Epigenome-wide association study on methamphetamine dependence
|
Apr 02, 2024 |
|
Lead: Disposable E-Cigarette Use and Subsequent Use Patterns in Adolescents and Young Adults
|
Mar 26, 2024 |
|
Lead: Adolescent Δ8-THC and Marijuana Use in the US
|
Mar 19, 2024 |
|
Lead: Association of Cannabis Use With Cardiovascular Outcomes Among US Adults
|
Mar 12, 2024 |
|
Lead: Racial and Ethnic Disparities in Geographic Availability of Buprenorphine
|
Mar 05, 2024 |
|
Lead: Smoking changes adaptive immunity with persistent effects
|
Feb 27, 2024 |
|
Lead: Overdose mortality incidence and supervised consumption services
|
Feb 20, 2024 |
|
Lead: Safety of e-cigarettes and nicotine patches as stop-smoking aids in pregnancy
|
Feb 13, 2024 |
|
Lead: Polysubstance mortality trends in White and Black Americans during the opioid epidemic
|
Feb 06, 2024 |
|
Lead: First Trimester Use of Buprenorphine or Methadone
|
Jan 30, 2024 |
|
Lead: Trends in hallucinogen-associated emergency department visits
|
Jan 23, 2024 |
|
Lead: Adolescent Residential Addiction Treatment In The US
|
Jan 17, 2024 |
|
Lead: Benzodiazepine Discontinuation and Mortality
|
Jan 09, 2024 |
|
ASAM Weekly Top 10 Peer reviewed Scientific Publications of 2023
|
Dec 28, 2023 |
|
Lead: Examining the benefit of a higher maintenance dose of extended-release buprenorphine
|
Dec 19, 2023 |
|
Lead: Relationship between alcohol use and firearm-involved suicide
|
Dec 12, 2023 |
|
Lead: Pregnancy and Postpartum Drug Overdose Deaths in the US Before and During the COVID-19 Pandemic
|
Dec 05, 2023 |
|
Lead: 2022 National Survey on Drug Use and Health
|
Nov 28, 2023 |
|
Lead: Fast dopamine increases drug reward
|
Nov 21, 2023 |
|
Lead: Public health approaches to gambling
|
Nov 15, 2023 |
|
Lead: Clinical Practice Guideline on the Management of Stimulant Use Disorder
|
Nov 07, 2023 |
|
Lead: Chronic pain, cannabis legalisation, and cannabis use disorder
|
Oct 31, 2023 |
|
Lead: Xylazine Adulteration of the Heroin–Fentanyl Drug Supply
|
Oct 24, 2023 |
|
Lead: Heterogeneous neuroimaging findings across substance use disorders localize to a common brain network
|
Oct 17, 2023 |
|
Lead: The association between temperature and alcohol- and substance-related disorder hospital visits
|
Oct 10, 2023 |
|
Lead: US tobacco companies selectively disseminated hyper-palatable foods into the US food system
|
Oct 03, 2023 |
|
Lead: America’s Opioid Ecosystem: How Leveraging System Interactions Can Help Curb Addiction, Overdose, and Other Harms
|
Sep 26, 2023 |
|
Lead: Naloxone Use in Novel Potent Opioid and Fentanyl Overdoses in Emergency Department Patients
|
Sep 19, 2023 |
|
Lead: Examining sociodemographic correlates of opioid use, misuse, and use disorders in the All of Us Research Program
|
Sep 19, 2023 |
|
Lead: Prevalence of Cannabis Use Disorder and Reasons for Use Among Adults in a US
|
Sep 12, 2023 |
|
Special Episode: ASAM Clinical Considerations: Buprenorphine Treatment of Opioid Use Disorder
|
Aug 31, 2023 |
|
Lead: Marijuana and hallucinogen use, binge drinking reached historic highs among adults 35 to 50
|
Aug 29, 2023 |
|
Lead: Perceptions of Safety of Daily Cannabis vs Tobacco Smoking and Secondhand Smoke Exposure
|
Aug 22, 2023 |
|
Lead: Alcohol Intake and Blood Pressure Levels
|
Aug 15, 2023 |
|
Special Episode: The Future of Psychedelic Therapy and Addiction Treatment
|
Aug 11, 2023 |
|
Lead: ASAM Clinical Considerations: Buprenorphine Treatment of Opioid Use Disorder
|
Aug 08, 2023 |
|
Lead: Recommendations for Reducing the Risk of Cannabis Use-Related Adverse Psychosis Outcomes
|
Aug 01, 2023 |
|
Lead: Examining the prevalence of mono-versus polysubstance use in the general population
|
Jul 25, 2023 |
|
Lead: Questioning the Right to Pain Relief and Its Role in the Opioid Epidemic
|
Jul 18, 2023 |
|
Lead: Xylazine effects on opioid-induced brain hypoxia
|
Jul 11, 2023 |
|
Lead: Psychedelics reopen the social reward learning critical period
|
Jul 04, 2023 |
|
Lead: Reduced Stress-Related Neural Network Activity Mediates the Effect of Alcohol on Cardiovascular Risk
|
Jun 27, 2023 |
|
Lead: Signaling-specific inhibition of the CB1 receptor for cannabis use disorder
|
Jun 20, 2023 |
|
Lead: Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression
|
Jun 13, 2023 |
|
Special Episode: Why Patients Transition Off Methadone
|
Jun 09, 2023 |
|
Lead: Increasing overdose deaths among Black Americans
|
Jun 06, 2023 |
|
Lead: Practice-Based Guidelines: Buprenorphine in the Age of Fentanyl
|
May 30, 2023 |
|
Lead: Racial Inequality in Receipt of Medications for Opioid Use Disorder
|
May 23, 2023 |
|
Lead: Eat, Sleep, Console Approach or Usual Care for Neonatal Opioid Withdrawal
|
May 16, 2023 |
|
Special Episode: Buprenorphine Initiation and the Howard Street Method
|
May 12, 2023 |
|
Lead: Subtypes in addiction and their neurobehavioral profiles across three functional domains
|
May 09, 2023 |
|
Lead: The conserved endocannabinoid anandamide modulates olfactory sensitivity to induce hedonic feeding in C. elegans
|
May 02, 2023 |
|
Lead: Opioid Prescribing and Suicide Risk in the United States
|
Apr 25, 2023 |
|
Lead: Association Between Daily Alcohol Intake and Risk of All-Cause Mortality
|
Apr 18, 2023 |
|
Lead: Genetic Liability for Alcohol Consumption, Alcohol Problems and Suicide Attempts
|
Apr 11, 2023 |
|
Lead: Genome-wide association study identifies loci underlying multiple substance use disorders
|
Apr 04, 2023 |
|
Special Episode: Emergency Room Treatment of AUD
|
Mar 30, 2023 |
|
Lead: Human brain effects of DMT assessed via EEG-fMRI
|
Mar 28, 2023 |
|
Lead: Characteristics of Fatal Poisonings Among Infants and Young Children in the United States
|
Mar 21, 2023 |
|
Lead: Synthesising evidence of the effects of COVID-19 regulatory changes on methadone treatment for opioid use disorder: implications for policy
|
Mar 14, 2023 |
|
Not all vaping is the same: differential pulmonary effects of vaping cannabidiol versus nicotine
|
Mar 07, 2023 |
|
Lead: The Howard Street Method: A Community Pharmacy-Led Low Dose Overlap Buprenorphine Initiation Protocol for Individuals Using Fentanyl
|
Feb 28, 2023 |
|
Lead: The Use of Opioids in the Management of Chronic Pain
|
Feb 21, 2023 |
|
Lead: State Cannabis Legalization and Psychosis-Related Health Care Utilization
|
Feb 14, 2023 |
|
Lead: Buprenorphine Dispensing Among Youth Aged ≤19 Years in the United States
|
Feb 07, 2023 |
|
Lead Story: Trends and Characteristics of Buprenorphine-Involved Overdose Deaths Prior to and During the COVID-19 Pandemic
|
Jan 31, 2023 |
|
Lead Story: Availability of best practices for opioid use disorder in jails and related training and resource needs
|
Jan 24, 2023 |
|
Lead Story: Postoperative Restrictive Opioid Protocols and Durable Changes in Opioid Prescribing and Chronic Opioid Use
|
Jan 17, 2023 |
|
Lead Story: A neuromarker for drug and food craving distinguishes drug users from non-users
|
Jan 10, 2023 |
|
Lead Story: On ‘Last Week Tonight,’ John Oliver Takes on the Nation’s Dumbest Drug Myth
|
Jan 03, 2023 |
|
Lead Story: Defining Recovery From Alcohol Use Disorder: Development of an NIAAA Research Definition
|
Dec 27, 2022 |
|
Lead Story: Genetic diversity fuels gene discovery for tobacco and alcohol use
|
Dec 20, 2022 |
|
Lead Story: Buprenorphine versus Methadone for Opioid Use Disorder in Pregnancy
|
Dec 13, 2022 |
|
Lead Story: Increased vulnerability to atrial and ventricular arrhythmias caused by different types of inhaled tobacco or marijuana products
|
Dec 06, 2022 |
|
Lead Story: Concurrent use of opioids and stimulants and risk of fatal overdose: A cohort study
|
Nov 29, 2022 |
|
Lead Story: Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression
|
Nov 22, 2022 |
|
Lead Story: Estimated Deaths Attributable to Excessive Alcohol Use Among US Adults Aged 20 to 64 Years, 2015 to 2019
|
Nov 15, 2022 |
|
Lead Story: Association Between Smoking, Smoking Cessation, and Mortality by Race, Ethnicity, and Sex Among US Adults
|
Nov 08, 2022 |
|
Lead Story: Physician Health Care Visits for Mental Health and Substance Use During the COVID-19 Pandemic in Ontario, Canada
|
Nov 01, 2022 |
|
Lead Story: National trends of suicidal ideation and mental health services use among US adults with opioid use disorder, 2009–2020
|
Oct 25, 2022 |
|
Lead Story: Association Between Buprenorphine Treatment Gaps, Opioid Overdose, and Health Care Spending in US Medicare Beneficiaries With Opioid Use Disorder
|
Oct 18, 2022 |
|
Lead Story: Impact of Administering Buprenorphine to Overdose Survivors Using Emergency Medical Services
|
Oct 11, 2022 |
|
Lead Story: Estimating the Prevalence of Substance Use Disorders in the US Using the Benchmark Multiplier Method
|
Oct 04, 2022 |
|
Lead Story: Association of State Child Abuse Policies and Mandated Reporting Policies With Prenatal and Postpartum Care Among Women Who Engaged in Substance Use During Pregnancy
|
Sep 27, 2022 |
|
Lead Story: Association of Mental Health Burden With Prenatal Cannabis Exposure From Childhood to Early Adolescence
|
Sep 20, 2022 |
|
Lead Story: Thirty Years of The ASAM Criteria: A Report Card
|
Sep 13, 2022 |
|
Lead Story: Receipt of Telehealth Services for OUD
|
Sep 06, 2022 |
|
Lead Story: Marijuana and hallucinogen use among young adults reached all time-high in 2021
|
Aug 30, 2022 |
|
Lead Story: Neurocognitive Performance and Brain Structure Associated With Initiation of Tobacco Use
|
Aug 23, 2022 |
|
Lead Story: Adolescent Use of Flavored Non-Tobacco Oral Nicotine Products
|
Aug 16, 2022 |
|
Lead Story: Impact of COVID-19 Telehealth Policy Changes on Buprenorphine Treatment for Opioid Use Disorder
|
Aug 09, 2022 |
|
Lead Story: Associations of Cannabis Potency with Mental Ill Health and Addiction: A Systemic Review
|
Aug 02, 2022 |
|
Lead Story: Drug Overdose Deaths, by Selected Sociodemographic and Social Determinants of Health Characteristics — 25 States and the District of Columbia, 2019–2020
|
Jul 26, 2022 |
|
Lead Story: Preaddiction—A Missing Concept for Treating Substance Use Disorders
|
Jul 19, 2022 |
|
Lead Story: Laws for expanding access to medications for opioid use disorder: a legal analysis of 16 states & Washington D.C
|
Jul 12, 2022 |
|
Lead Story: Reducing Opioid Use Disorder and Overdose Deaths in the United States: A Dynamic Modeling Analysis
|
Jul 05, 2022 |
|
Lead Story: Long-term Risk of Overdose or Mental Health Crisis After Opioid Dose Tapering
|
Jun 28, 2022 |